Stephen Kingsmore Archives

Media Coverage
March 28, 2023

The doctor will see your phone now: Sequencing and speedy diagnosis give chance of timely care

New Zealand Doctor

NEW ZEALAND DOCTOR: In this cover story, journalist Alan Perrott grills a leader in genome sequencing and artificial intelligence on the future of healthcare.

Media Coverage
February 28, 2023

It takes an average of 8 years for a rare disease patient to get diagnosed. Why is it so hard to get life-altering genetic testing in the U.S.?

Fortune

Fortune: No one wants to find themselves sick or in need of a medical diagnosis. But there are those out there who already are—and are desperately seeking answers.

Media Coverage
February 28, 2023

Communications Medicine Q&A With Dr. Stephen Kingsmore

Nature Communications Medicine

NATURE COMMUNICATIONS MEDICINE: Stephen Kingsmore talks about the challenges in diagnosing rare diseases and how diagnosis could be improved in the future.

Media Coverage
February 15, 2023

Precision medicine in Asia: Leaping evolution improves diagnosis rate and catches rare diseases

Global Bio & Investment

Global Bio & Investment: RCIGM CEO Stephen F. Kingsmore spoke at the Asia-Pacific Forum on Population Genomics and Precision Medicine.

Media Coverage
February 14, 2023

Stephen Kingsmore’s quest to test every baby with genome sequencing

The Harry Glorikian Show

The Harry Glorikian Show: Stephen Kingsmore talks with Harry Glorikian about the power of rapid Whole Genome Sequencing™, how far we've come in adoption, and much more.

Media Coverage
February 9, 2023

Study suggests DNA sequencing could reduce infant deaths, often caused by genetic disease

STAT

Press Releases
February 9, 2023

Study Finds Association of Genetic Disease and Infant Mortality Higher Than Previously Recognized: 41% of Infant Deaths Associated with Genetic Diseases

Rapid, Diagnostic Whole Genome Sequencing May Have Prevented Deaths in Some Cases

Press Releases
November 7, 2022

Stephen Kingsmore, MD Named Inaugural David F. Hale Chair in Pediatric Genomic Medicine

Rady Children’s Institute for Genomic Medicine® (RCIGM) President & CEO Stephen Kingsmore, MD, DSc, was formally inducted today as the David F. Hale Chair in Pediatric Genomic Medicine. Serving as an endowed chair is one of the highest honors in academic medicine.

Media Coverage
October 6, 2022

Nanopore Sequencing Rapidly Advances, Enabling Genetic Assessment of Newborn in Three Hours

GenomeWeb

GENOMEWEB: RCIGM President & CEO Stephen Kingsmore provides context for the nanopore's latest three-hour sequencing announcement.

Press Releases
June 29, 2022

News Center Archives

About us

Tag: Stephen Kingsmore

The doctor will see your phone now: Sequencing and speedy diagnosis give chance of timely care

It takes an average of 8 years for a rare disease patient to get diagnosed. Why is it so hard to get life-altering genetic testing in the U.S.?

Communications Medicine Q&A With Dr. Stephen Kingsmore

Precision medicine in Asia: Leaping evolution improves diagnosis rate and catches rare diseases

Stephen Kingsmore’s quest to test every baby with genome sequencing

Study suggests DNA sequencing could reduce infant deaths, often caused by genetic disease

Study Finds Association of Genetic Disease and Infant Mortality Higher Than Previously Recognized: 41% of Infant Deaths Associated with Genetic Diseases

Stephen Kingsmore, MD Named Inaugural David F. Hale Chair in Pediatric Genomic Medicine

Nanopore Sequencing Rapidly Advances, Enabling Genetic Assessment of Newborn in Three Hours

Dr. Stephen Kingsmore Receives Prestigious Precision Medicine World Conference 2022 Luminary Award

Partner With Us

Order a Test

About Us

STAY UP TO DATE

Follow Us

Contact Us About BeginNGS